13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 44 holding rows worth $509,321,573.
- Accession
- 0001172661-23-002293
- Filer
- CIK 1281446
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 44 entries on the cover page, a total value of $509,321,573 stated on the cover page (in dollars after the unit check, H1), rows summing to $509,321,573 with VALUE read as dollars as filed, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerYehudai Ortav028-20398
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,212,096 | $32,241,754 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 818,505 | $29,294,294 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 3,740,761 | $28,878,675 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 677,426 | $27,164,783 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,355,151 | $24,867,021 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 659,211 | $24,707,228 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 3,383,029 | $24,594,621 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 783,795 | $22,996,545 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,003,000 | $22,557,470 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 149,500 | $21,876,335 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 2,192,816 | $18,551,223 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 500,000 | $17,595,000 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 804,333 | $17,502,286 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 694,009 | $16,885,239 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,000,000 | $16,650,000 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 755,620 | $15,240,855 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 7,894,736 | $15,236,840 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 255,367 | $12,625,344 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,600,545 | $12,580,284 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 658,127 | $10,839,352 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 620,326 | $9,714,305 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,191,581 | $9,639,890 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 5,817,368 | $8,784,226 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 257,006 | $7,918,355 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 8,099,799 | $6,104,009 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 278,334 | $5,953,564 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 3,153,206 | $5,864,963 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 507,500 | $4,425,400 | dollars as filed | |
| GENERATION BIO CO | 37148K100 | COM | 1,022,537 | $4,396,909 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 1,051,267 | $4,268,144 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 380,000 | $4,214,200 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 900,000 | $4,077,000 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 70,371 | $3,810,590 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 250,000 | $3,807,500 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 250,000 | $2,022,500 | dollars as filed | call |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 347,824 | $1,913,032 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 141,526 | $1,892,203 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 97,544 | $1,740,185 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 2,032,550 | $1,644,333 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 80,000 | $1,332,000 | dollars as filed | put |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 210,405 | $997,320 | dollars as filed | |
| AVALO THERAPEUTICS INC COM NEW | 05338F207 | Stock | 474,639 | $830,618 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 120,864 | $722,767 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 39,222 | $362,411 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-23-002293 | this filing | 2023-05-15 | acceptance time not in the bulk data set |